Phase II trial of chlorozotocin and fluorouracil in islet cell carcinoma: a Southwest Oncology Group study

scientific article published on 01 December 1992

Phase II trial of chlorozotocin and fluorouracil in islet cell carcinoma: a Southwest Oncology Group study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1200/JCO.1992.10.12.1914
P953full work available at URLhttp://intl.jco.org/cgi/content/abstract/10/12/1914
P698PubMed publication ID1333517

P2093author name stringR. Lee
A. B. Einstein
R. Peterson
C. Tangen
R. M. Bukowski
J. S. Macdonald
T. R. Fleming
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectphase II clinical trialQ42824440
islet cell carcinomaQ6084258
fluorouracilQ238512
P304page(s)1914-1918
P577publication date1992-12-01
P1433published inJournal of Clinical OncologyQ400292
P1476titlePhase II trial of chlorozotocin and fluorouracil in islet cell carcinoma: a Southwest Oncology Group study
P478volume10

Reverse relations

cites work (P2860)
Q37077832Biology and treatment of metastatic gastrointestinal neuroendocrine tumors.
Q41439948Gastrointestinal endocrine tumours. Gastrinoma
Q43754199Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282.
Q38035223Streptozocin-based chemotherapy is not history in neuroendocrine tumours
Q36904573Treatment of gastroenteropancreatic neuroendocrine tumors
Q74286331[Pancreatic neuroendocrine tumors: how far have we gone ahead?]

Search more.